Pseudomonas aeruginosa in a neonatal intensive care unit: molecular epidemiology and infection control measures

Valeria Crivaro1, Anna Di Popolo, Alessandro Caprio

  • 1Dipartimento di Scienze Mediche Preventive, Sezione di Igiene, Università Federico II, Napoli, Italy. v.crivaro@virgilio.it

Abstract

Insights

Pseudomonas aeruginosa infections in neonatal intensive care units (NICUs) were controlled by an enhanced infection control program. This included active surveillance and strict hand hygiene, reducing NICU-acquired infections and colonizations.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Hospital Epidemiology

Background:

  • Pseudomonas aeruginosa is a common cause of diverse infections in neonatal intensive care unit (NICU) patients.
  • An increase in P. aeruginosa infections and colonizations was noted in our NICU between 2005 and 2007.

Purpose of the Study:

  • To describe the molecular epidemiology of P. aeruginosa in the NICU.
  • To evaluate the effectiveness of infection control measures implemented to curb the spread of P. aeruginosa.

Main Methods:

  • Hand hygiene compliance was assessed before and after an educational program.
  • Microorganism identification, antibiotic susceptibility testing (MIC microdilution), and genotyping (PFGE analysis) were performed.
  • Active surveillance for healthcare-associated infections and environmental microbiological sampling were conducted.

Main Results:

  • P. aeruginosa was isolated from 135 neonates, causing severe infections in 11 between July 2005 and June 2007.
  • PFGE analysis identified 20 distinct genotypes, with one major type (A) found in 48 patients and responsible for 4 infections.
  • Environmental strains with PFGE profiles identical to clinical isolates were found on a nurse's hand and in sinks, indicating potential transmission routes.

Conclusions:

  • NICU P. aeruginosa infections stemmed from both epidemic clone cross-transmission and sporadic clone selection.
  • An infection control program incorporating active surveillance and stringent hand disinfection policies effectively managed NICU-acquired P. aeruginosa infections and colonizations.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...